Genprex
GNPX
Genprex (GNPX) news
Recent news
Genprex - expects to complete validation studies by end of 2026
AInvest Wire · Aug 3, 2026Genprex Inc files for mixed shelf of up to $250 mln – SEC filing
AInvest Wire · Jun 5, 2026ImportantGenprex Shares Climb After First Patient Dosing in Reqorsa-Tagrisso Trial
Genprex Shares Climb After First Patient Dosing in Reqorsa-Tagrisso Trial Genprex Shares Climb After First Patient Dosing in Reqorsa-Tagrisso Trial Genprex, a clinical-stage gene therapy company, has announced the first patient dosing in its Phase 2a expansion study of REQORSA® Therapy in…
AInvest Wire · Feb 5, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.